Signal Transduction and Targeted Therapy (Apr 2021)
SAHA attenuates Takotsubo-like myocardial injury by targeting an epigenetic Ac/Dc axis
- Ishant Khurana,
- Scott Maxwell,
- Simon Royce,
- Prabhu Mathiyalagan,
- Tom Karagiannis,
- Nadia Mazarakis,
- Jitraporn Vongsvivut,
- Harikrishnan K.N.,
- Jun Okabe,
- Keith Al-Hasani,
- Chrishan Samuel,
- Assam El-Osta
Affiliations
- Ishant Khurana
- Human Epigenetics Program, Department of Diabetes, Central Clinical School, Monash University
- Scott Maxwell
- Human Epigenetics Program, Department of Diabetes, Central Clinical School, Monash University
- Simon Royce
- Cardiovascular Disease Program, Monash Biomedicine Discovery Institute and Department of Pharmacology, Monash University
- Prabhu Mathiyalagan
- Human Epigenetics Program, Department of Diabetes, Central Clinical School, Monash University
- Tom Karagiannis
- Human Epigenetics Program, Department of Diabetes, Central Clinical School, Monash University
- Nadia Mazarakis
- Human Epigenetics Program, Department of Diabetes, Central Clinical School, Monash University
- Jitraporn Vongsvivut
- Infrared Microspectroscopy Beamline, ANSTO - Australian Synchrotron
- Harikrishnan K.N.
- Human Epigenetics Program, Department of Diabetes, Central Clinical School, Monash University
- Jun Okabe
- Human Epigenetics Program, Department of Diabetes, Central Clinical School, Monash University
- Keith Al-Hasani
- Human Epigenetics Program, Department of Diabetes, Central Clinical School, Monash University
- Chrishan Samuel
- Cardiovascular Disease Program, Monash Biomedicine Discovery Institute and Department of Pharmacology, Monash University
- Assam El-Osta
- Human Epigenetics Program, Department of Diabetes, Central Clinical School, Monash University
- DOI
- https://doi.org/10.1038/s41392-021-00546-y
- Journal volume & issue
-
Vol. 6,
no. 1
pp. 1 – 4
Abstract
No abstracts available.